Related Experiment Video
Updated: Aug 23, 2026
An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 18, 2013
Microarray analysis of differential gene expression in androgen independent prostate cancer using a metastatic human
K C Balaji1, Prema S Rao, David J Smith
1Department of Surgery, Division of Urology, University of Nebraska Medical Center, Omaha, NE 68198-2360, USA. kcbalaji@unmc.edu
Abstract:
Progression to androgen independence (AI) leading to uncontrolled cell growth is the main cause of death in prostate cancer. While almost all patients with metastatic prostate cancer will initially respond to anti-androgen treatments, the majority will fail hormonal treatments in less than 2 yrs. Both genetic and epigenetic alterations in gene expression contribute significantly to the development of AI. To investigate this we have used an in vitro cell line model of AI prostate cancer from which we have identified a number of differentially expressed genes associated with progression to AI in prostate cancer. We used an in vitro cell line model of AI prostate cancer, to study differential gene expression using cDNA microarray analysis and corroborated the microarray results with Ribonuclease Protection Assay (RPA). Approximately 4480 out of 7075 (63.3%) cDNA cloned genes were differentially expressed, of which, 6 genes were differentially expressed by at least fivefold. RPA was used to corroborate the microarray results for the five most highly differentially expressed genes. Using an in vitro cell line model and microarray analysis we have identified a number of candidate genes for further investigation in AI prostate cancer.
Insights
Prostate cancer progression to androgen independence (AI) involves gene expression changes. This study identified candidate genes associated with AI progression using cell line models and microarray analysis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Prostate cancer progression to androgen independence (AI) leads to uncontrolled cell growth and is a primary cause of cancer-related death.
- Most patients with metastatic prostate cancer initially respond to anti-androgen therapies, but resistance develops within two years.
- Genetic and epigenetic alterations in gene expression are significant contributors to the development of AI.
Purpose of the Study:
- To investigate gene expression changes associated with the progression to androgen independence (AI) in prostate cancer.
- To identify candidate genes that play a role in the development of AI using an in vitro cell line model.
Main Methods:
- Utilized an in vitro cell line model of androgen-independent (AI) prostate cancer.
- Employed cDNA microarray analysis to study differential gene expression.
- Corroborated microarray findings using Ribonuclease Protection Assay (RPA).
Main Results:
- Out of 7075 cDNA cloned genes analyzed, 4480 (63.3%) were differentially expressed.
- Six genes exhibited differential expression of at least fivefold.
- RPA confirmed microarray results for the five most highly differentially expressed genes.
Conclusions:
- Microarray analysis of an in vitro AI prostate cancer model identified numerous differentially expressed genes.
- Several candidate genes were identified for further investigation in the context of AI prostate cancer progression.
- This research provides insights into the molecular mechanisms underlying the transition to androgen independence in prostate cancer.
